Literature DB >> 34190147

Thrombomodulin gene polymorphism and the occurrence and prognostic value of sepsis acute kidney injury.

Qin Li1, Wenjuan Yang1, Keming Zhao1, Xifeng Sun1, Liuqian Bao2.   

Abstract

ABSTRACT: To investigate the relationship between thrombomodulin (THBD) gene single nucleotide polymorphisms (SNPs) and susceptibility to sepsis and the occurrence and prognosis of acute kidney injury (AKI) in sepsis patients.The genotypes of THBD gene rs1962, rs3176123, and rs1042580 in 178 sepsis patients with AKI, 243 sepsis patients without AKI (No AKI), and 103 healthy controls were analyzed by direct sequencing. Enzyme-linked immunosorbent assay (ELISA) was used to detect the plasma THBD protein levels. Receiver operating characteristic (ROC) curve analysis was performed to evaluate the diagnostic value of plasma THBD levels in sepsis, AKI, and death of sepsis patients.The C allele carriers of THBD gene rs1962 were more likely to develop AKI and sepsis than the T allele carriers (OR = 1.61, 95% CI: 1.18-2.19, P < .01; OR = 2.16, 95% CI: 1.42-3.29, P < .01). The rs3176123 G allele was associated with an increased risk of AKI in sepsis patients (OR = 1.41, 95% CI: 1.06-1.88, P = .02), the G allele had a significant association with a higher risk of sepsis susceptibility (OR = 1.91, 95% CI: 1.33-2.75, P < .01). Sepsis patients of rs1042580 C allele had a lower risk of AKI than those of T allele (OR = 0.58, 95% CI: 0.37-0.91, P = .02), the C allele was related to a reduced risk of sepsis susceptibility (OR = 0.38, 95% CI: 0.26-0.55, P < .01). The THBD gene rs1962, rs3176123, and rs1042580 TGT haplotype was linked to higher risk of AKI in patients with sepsis (OR = 1.96, 95%CI: 1.14-3.38, P = .02). Sepsis patients with the THBD gene rs1962 TC + CC genotype had a higher risk of death than those with TT genotype (OR = 10.93, 95%CI: 5.05-26.96, P < .01), but there was no significant difference in the risk of death in sepsis patients with different genotypes at rs3176123 and rs1042580 (P > .05).The THBD gene rs1962, rs3176123, and rs1042580 SNPs are significantly associated with sepsis susceptibility and the risk of AKI. The rs1962 SNP is related to the risk of death in sepsis patients.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34190147      PMCID: PMC8257907          DOI: 10.1097/MD.0000000000026293

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


  29 in total

1.  Sepsis and endothelial permeability.

Authors:  Warren L Lee; Arthur S Slutsky
Journal:  N Engl J Med       Date:  2010-08-12       Impact factor: 91.245

2.  Acute renal failure: an unacceptable death sentence globally.

Authors:  Giuseppe Remuzzi; Richard Horton
Journal:  Lancet       Date:  2013-12-21       Impact factor: 79.321

3.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).

Authors:  Mervyn Singer; Clifford S Deutschman; Christopher Warren Seymour; Manu Shankar-Hari; Djillali Annane; Michael Bauer; Rinaldo Bellomo; Gordon R Bernard; Jean-Daniel Chiche; Craig M Coopersmith; Richard S Hotchkiss; Mitchell M Levy; John C Marshall; Greg S Martin; Steven M Opal; Gordon D Rubenfeld; Tom van der Poll; Jean-Louis Vincent; Derek C Angus
Journal:  JAMA       Date:  2016-02-23       Impact factor: 56.272

4.  Thrombomodulin-dependent protein C activation is required for mitochondrial function and myelination in the central nervous system.

Authors:  J Wolter; L Schild; F Bock; A Hellwig; I Gadi; M M Al-Dabet; S Ranjan; R Rönicke; P P Nawroth; K-U Petersen; C Mawrin; K Shahzad; B Isermann
Journal:  J Thromb Haemost       Date:  2016-10-20       Impact factor: 5.824

5.  Anti-inflammatory mechanism of ulinastatin: Inhibiting the hyperpermeability of vascular endothelial cells induced by TNF-α via the RhoA/ROCK signal pathway.

Authors:  Fu Wei; Siyi Liu; Li Luo; Nina Gu; Yan Zeng; Xiaoying Chen; Shan Xu; Dan Zhang
Journal:  Int Immunopharmacol       Date:  2017-03-19       Impact factor: 4.932

6.  Thrombomodulin gene polymorphisms and haplotypes and the risk of cardiovascular events: a prospective follow-up study.

Authors:  K Auro; K Komulainen; M Alanne; K Silander; L Peltonen; M Perola; V Salomaa
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-02-02       Impact factor: 8.311

Review 7.  Sepsis-associated acute kidney injury.

Authors:  Rashid Alobaidi; Rajit K Basu; Stuart L Goldstein; Sean M Bagshaw
Journal:  Semin Nephrol       Date:  2015-01       Impact factor: 5.299

8.  Recombinant human soluble thrombomodulin improves mortality and respiratory dysfunction in patients with severe sepsis.

Authors:  Yoshihito Ogawa; Kazuma Yamakawa; Hiroshi Ogura; Takeyuki Kiguchi; Tomoyoshi Mohri; Yasushi Nakamori; Yasuyuki Kuwagata; Takeshi Shimazu; Toshimitsu Hamasaki; Satoshi Fujimi
Journal:  J Trauma Acute Care Surg       Date:  2012-05       Impact factor: 3.313

9.  Single-Nucleotide Polymorphisms Within the Thrombomodulin Gene (THBD) Predict Mortality in Patients With Graft-Versus-Host Disease.

Authors:  Sivaramakrishna P Rachakonda; Olaf Penack; Sascha Dietrich; Olga Blau; Igor Wolfgang Blau; Aleksandar Radujkovic; Berend Isermann; Anthony D Ho; Lutz Uharek; Peter Dreger; Rajiv Kumar; Thomas Luft
Journal:  J Clin Oncol       Date:  2014-09-15       Impact factor: 44.544

10.  Predictive Performance of the Simplified Acute Physiology Score (SAPS) II and the Initial Sequential Organ Failure Assessment (SOFA) Score in Acutely Ill Intensive Care Patients: Post-Hoc Analyses of the SUP-ICU Inception Cohort Study.

Authors:  Anders Granholm; Morten Hylander Møller; Mette Krag; Anders Perner; Peter Buhl Hjortrup
Journal:  PLoS One       Date:  2016-12-22       Impact factor: 3.240

View more
  1 in total

1.  A Thrombomodulin Promoter Gene Polymorphism, rs2239562, Influences Both Susceptibility to and Outcome of Sepsis.

Authors:  Eizo Watanabe; Osamu Takasu; Youichi Teratake; Teruo Sakamoto; Toshiaki Ikeda; Joji Kotani; Nobuya Kitamura; Masaaki Ohmori; Ayako Teratani; Goichi Honda; Masahiko Hatano; Benjamin Mayer; E Marion Schneider; Shigeto Oda
Journal:  Front Med (Lausanne)       Date:  2022-01-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.